Boston Scientific EBITDA 2006-2019 | BSX

Boston Scientific annual and quarterly EBITDA history from 2006 to 2019. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Boston Scientific EBITDA for the quarter ending September 30, 2019 was $0.383B, a 1.54% decline year-over-year.
  • Boston Scientific EBITDA for the twelve months ending September 30, 2019 was $1.626B, a 7.9% increase year-over-year.
  • Boston Scientific 2018 annual EBITDA was $2.435B, a 14.16% increase from 2017.
  • Boston Scientific 2017 annual EBITDA was $2.133B, a 67.56% increase from 2016.
  • Boston Scientific 2016 annual EBITDA was $1.273B, a 152.08% increase from 2015.
Boston Scientific Annual EBITDA
(Millions of US $)
2018 $2,435
2017 $2,133
2016 $1,273
2015 $505
2014 $619
2013 $1,285
2012 $1,307
2011 $2,339
2010 $2,042
2009 $-48
2008 $2,149
2007 $925
2006 $-2,168
2005 $1,282
Boston Scientific Quarterly EBITDA
(Millions of US $)
Q3 2019 $383
Q2 2019 $384
Q1 2019 $541
Q4 2018 $318
Q3 2018 $389
Q2 2018 $391
Q1 2018 $408
Q4 2017 $319
Q3 2017 $377
Q2 2017 $225
Q1 2017 $364
Q4 2016 $140
Q3 2016 $348
Q2 2016 $-334
Q1 2016 $293
Q4 2015 $-227
Q3 2015 $-299
Q2 2015 $219
Q1 2015 $24
Q4 2014 $-493
Q3 2014 $64
Q2 2014 $-69
Q1 2014 $197
Q4 2013 $127
Q3 2013 $103
Q2 2013 $220
Q1 2013 $-330
Q4 2012 $117
Q3 2012 $-594
Q2 2012 $-3,587
Q1 2012 $196
Q4 2011 $171
Q3 2011 $174
Q2 2011 $237
Q1 2011 $322
Q4 2010 $348
Q3 2010 $251
Q2 2010 $231
Q1 2010 $-1,486
Q4 2009 $-1,231
Q3 2009 $51
Q2 2009 $275
Q1 2009 $11
Q4 2008 $-2,416
Q3 2008 $28
Q2 2008 $303
Q1 2008 $580
Q4 2007 $-429
Q3 2007 $-147
Q2 2007 $280
Q1 2007 $282
Q4 2006 $284
Q3 2006 $195
Q2 2006 $-3,925
Q1 2006 $497
Q4 2005 $465
Q3 2005 $-336
Q2 2005 $326
Q1 2005 $513
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $57.453B $9.823B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.152B 27.21
Medtronic (MDT) Ireland $145.746B 20.46
Stryker (SYK) United States $74.888B 25.18
Baxter (BAX) United States $40.896B 24.80
EssilorLuxottica Societe Anonyme (ESLOY) France $32.537B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.730B 18.65
Terumo (TRUMY) Japan $26.750B 33.38
Coloplast (CLPBY) Denmark $25.121B 40.10
Lonza Group Ag (LZAGY) Switzerland $24.554B 0.00
ResMed (RMD) United States $20.727B 38.24
Smith & Nephew SNATS (SNN) United Kingdom $18.483B 0.00
Sunny Optical Technology (SNPTF) China $18.021B 0.00
Insulet (PODD) United States $10.961B 521.47
Bio-Rad Laboratories (BIO) United States $10.558B 50.68
Hill-Rom Holdings (HRC) United States $6.990B 20.59
Canopy Growth (CGC) Canada $6.705B 0.00
William Demant Holdings (WILYY) Denmark $6.665B 0.00
Perrigo (PRGO) Ireland $6.573B 12.26
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.116B 41.33
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.780B 29.76
ICU Medical (ICUI) United States $3.692B 24.08
Aurora Cannabis (ACB) Canada $3.673B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.379B 0.00
Neogen (NEOG) United States $3.366B 56.32
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.995B 0.00
Quidel (QDEL) United States $2.491B 23.64
National Vision Holdings (EYE) United States $2.138B 48.26
Agios Pharmaceuticals (AGIO) United States $2.001B 0.00
Cardiovascular Systems (CSII) United States $1.547B 0.00
InMode (INMD) Israel $1.405B 0.00
VAREX IMAGING (VREX) United States $1.255B 25.13
Aphria (APHA) $1.195B 0.00
AtriCure (ATRC) United States $1.111B 0.00
Phibro Animal Health (PAHC) United States $0.921B 17.24
NanoString Technologies (NSTG) United States $0.824B 0.00
Lantheus Holdings (LNTH) United States $0.824B 20.58
Eagle Pharmaceuticals (EGRX) United States $0.797B 30.55
TG Therapeutics (TGTX) United States $0.718B 0.00
LeMaitre Vascular (LMAT) United States $0.683B 38.39
Omeros (OMER) United States $0.675B 0.00
PetIQ (PETQ) United States $0.632B 15.45
Quanterix (QTRX) United States $0.628B 0.00
Cerus (CERS) United States $0.601B 0.00
HEXO (HEXO) $0.545B 0.00
Surmodics (SRDX) United States $0.531B 55.44
OraSure Technologies (OSUR) United States $0.507B 30.41
Organigram Holdings (OGI) Canada $0.426B 0.00
Owens & Minor (OMI) United States $0.422B 15.60
MacroGenics (MGNX) United States $0.404B 0.00
Utah Medical Products (UTMD) United States $0.376B 27.22
Meridian Bioscience (VIVO) United States $0.348B 11.98
BioLife Solutions (BLFS) United States $0.338B 138.25
Zynex (ZYXI) United States $0.298B 33.67
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.289B 0.00
Bovie Medical (APYX) United States $0.271B 0.00
Viemed Healthcare (VMD) United States $0.258B 0.00
United Health Products (UEEC) United States $0.214B 0.00
Vapotherm (VAPO) United States $0.200B 0.00
Repro-Med Systems (KRMD) United States $0.174B 0.00
InfuSystems Holdings (INFU) United States $0.144B 0.00
Cytosorbents (CTSO) United States $0.142B 0.00
Fonar (FONR) United States $0.131B 9.24
Liberty Health Sciences (LHSIF) Canada $0.130B 0.00
Rockwell Medical (RMTI) United States $0.125B 0.00
Female Health (VERU) United States $0.125B 0.00
Chimerix (CMRX) United States $0.109B 0.00
United-Guardian (UG) United States $0.088B 22.30
Chembio Diagnostics (CEMI) United States $0.077B 0.00
Nephros (NEPH) United States $0.066B 0.00
MRI Interventions (MRIC) United States $0.056B 0.00
Surface Oncology (SURF) United States $0.047B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.045B 0.00
MTech Acquisition (KERN) United States $0.043B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Senestech (SNES) United States $0.022B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Myomo (MYO) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00